MASSIDDA: "Disciplina delle medicine non convenzionali" (2824)

This procedure concerns the regulation of unconventional medicines within Italy. It aims to establish clear rules for their use and accessibility, potentially impacting patients and healthcare providers. The legislation will affect individuals seeking or providing alternative therapies, as well as the broader healthcare system by defining the legal status and oversight of these treatments.